Why Has Chardan Capital Markets Given Voyager Therapeutics (NASDAQ:VYGR) a $20.0 Price Target Chardan Capital Markets commenced coverage its coverage for Voyager Therapeutics (NASDAQ:VYGR), this…
Why Has Chardan Capital Markets Given Voyager Therapeutics (NASDAQ:VYGR) a $20 Price Target In a note issued to clients and investors on Wednesday, 9 December,…
Why Has Piper Jaffray Given Voyager Therapeutics (NASDAQ:VYGR) a $47.0 Price Target Piper Jaffray analyst launched coverage with a Overweight rating on Voyager Therapeutics (NASDAQ:VYGR)…
Why Has Wedbush Given Voyager Therapeutics (NASDAQ:VYGR) a $36.0 Price Target In a note issued to clients today, Wedbush analysts have commenced coverage Voyager Therapeutics…
Why Has Piper Jaffray Given Voyager Therapeutics (NASDAQ:VYGR) a $47 Price Target Professional analysts at Piper Jaffray placed a key Overweight rating for Voyager Therapeutics…
Why Has Wedbush Given Voyager Therapeutics (NASDAQ:VYGR) a $36 Price Target Expert analysts at Wedbush launched coverage on Voyager Therapeutics (NASDAQ:VYGR) with a key “Outperform”…
